| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	TrueBlue (NYSE:TBI) sees Q4 sales of $399.000 million-$424.000 million vs $410.873 million analyst estimate.
																	TrueBlue (NYSE:TBI) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 136....
																	
																	
																	BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and raises the price target from $7 to $8.
																	TrueBlue (NYSE:TBI) sees Q3 sales of $400.000 million-$425.000 million vs $393.204 million analyst estimate.
																	TrueBlue (NYSE:TBI) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 28.5...